• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎疫情的快速和有效遏制。广州经验分享。

How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share.

机构信息

Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China.

National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

出版信息

Front Public Health. 2022 Dec 21;10:979063. doi: 10.3389/fpubh.2022.979063. eCollection 2022.

DOI:10.3389/fpubh.2022.979063
PMID:36620243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9812567/
Abstract

INTRODUCTION

SARS-CoV-2 has ravaged the world and undergone multiple mutations during the course of the COVID-19 pandemic. On 7 April 2022, an epidemic caused by SARS-CoV-2 Omicron (BA.2) variant broke out in Guangzhou, China, one of the largest transportation and logistical hubs of the country.

METHODS

To fast curtained the Omicron epidemic, based on the routine surveillance on the risk population of SARS-CoV-2 infection, we identify key places of the epidemic and implement enhanced control measures against Omicron.

RESULTS

Transmission characteristics of the Omicron variant were analyzed for 273 confirmed cases, and key places involved in this epidemic were fully presented. The median incubation time and the generation time were 3 days, and the reproduction number Rt was sharply increased with a peak of 4.20 within 2 days. We tried an all-out effort to tackle the epidemic in key places, and the proportion of confirmed cases increased from 61.17% at Stage 2 to 88.89% at Stage 4. Through delimited risk area management, 99 cases were found, and the cases were isolated in advance for 2.61 ± 2.76 days in a lockdown zone, 0.44 ± 1.08 days in a controlled zone, and 0.27 ± 0.62 days in a precautionary zone. People assigned with yellow code accounted for 30.32% (84/277) of confirmed COVID-19 cases, and 83.33% of them were detected positive over 3 days since code assignment. For the districts outside the epicenter, the implementation duration of NPIs was much shorter compared with the Delta epidemic last year.

CONCLUSION

By blocking out transmission risks and adjusting measures to local epidemic conditions through the all-out effort to tackle the epidemic in key places, by delimiting risk area management, and by conducting health code management of the at-risk population, the Omicron epidemic could be contained quickly.

摘要

简介

SARS-CoV-2 在 COVID-19 大流行期间经历了多次突变,肆虐全球。2022 年 4 月 7 日,中国最大的交通和物流枢纽之一广州爆发了由 SARS-CoV-2 奥密克戎(BA.2)变体引起的疫情。

方法

为了迅速控制奥密克戎疫情,我们根据对 SARS-CoV-2 感染高危人群的常规监测,确定疫情关键地点,并实施针对奥密克戎的强化控制措施。

结果

对 273 例确诊病例的奥密克戎变异传播特征进行了分析,并充分展示了此次疫情涉及的关键地点。中位潜伏期和世代时间为 3 天,Rt 繁殖数在 2 天内急剧增加,峰值达到 4.20。我们全力以赴处理关键地点的疫情,确诊病例比例从第 2 阶段的 61.17%上升到第 4 阶段的 88.89%。通过划定风险区域管理,共发现 99 例病例,封控区病例提前隔离 2.61±2.76 天,管控区 0.44±1.08 天,防范区 0.27±0.62 天。健康码赋黄码人员占 277 例确诊 COVID-19 病例的 30.32%(84/277),自赋码起 3 天内检测阳性的比例为 83.33%。对于非疫情中心区,与去年德尔塔疫情相比,实施非药物干预措施的持续时间要短得多。

结论

通过在关键地点全力以赴处理疫情、通过划定风险区域管理、通过对高危人群进行健康码管理,阻断传播风险,根据疫情形势调整措施,可以迅速控制奥密克戎疫情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/9c34c946be8c/fpubh-10-979063-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/acd1657016b4/fpubh-10-979063-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/23c1c9208293/fpubh-10-979063-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/c74e9826ff5b/fpubh-10-979063-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/3cd6845e4f46/fpubh-10-979063-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/19af4bb72bed/fpubh-10-979063-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/9df7cdb17914/fpubh-10-979063-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/9c34c946be8c/fpubh-10-979063-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/acd1657016b4/fpubh-10-979063-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/23c1c9208293/fpubh-10-979063-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/c74e9826ff5b/fpubh-10-979063-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/3cd6845e4f46/fpubh-10-979063-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/19af4bb72bed/fpubh-10-979063-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/9df7cdb17914/fpubh-10-979063-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/9812567/9c34c946be8c/fpubh-10-979063-g0007.jpg

相似文献

1
How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share.奥密克戎疫情的快速和有效遏制。广州经验分享。
Front Public Health. 2022 Dec 21;10:979063. doi: 10.3389/fpubh.2022.979063. eCollection 2022.
2
[Epidemiological characteristics of two local COVID-19 outbreaks caused by 2019-nCoV Omicron variant in Guangzhou, China].[中国广州2019-nCoV奥密克戎变异株引起的两起本地新冠肺炎疫情的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Nov 10;43(11):1705-1710. doi: 10.3760/cma.j.cn112338-20220523-00450.
3
Age-specific transmission dynamics under suppression control measures during SARS-CoV-2 Omicron BA.2 epidemic.奥密克戎 BA.2 流行期间抑制控制措施下的特定年龄传播动力学。
BMC Public Health. 2023 Apr 22;23(1):743. doi: 10.1186/s12889-023-15596-w.
4
Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau.奥密克戎变异株 BA.5 传染性强但可防可控:澳门的成功经验。
Front Public Health. 2023 Jan 10;10:1029171. doi: 10.3389/fpubh.2022.1029171. eCollection 2022.
5
Transmission dynamics and successful control measures of SARS-CoV-2 in the mega-size city of Guangzhou, China.中国特大型城市广州的 SARS-CoV-2 传播动力学和成功控制措施。
Medicine (Baltimore). 2021 Dec 3;100(48):e27846. doi: 10.1097/MD.0000000000027846.
6
Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.基于截至 2022 年 3 月 1 日中国所有本地疫情的发病数据,比较不同 COVID-19 株的流行病学特征和传播性。
Front Public Health. 2022 Sep 15;10:949594. doi: 10.3389/fpubh.2022.949594. eCollection 2022.
7
Is Omicron the last SARS-CoV-2 Variant of Concern?奥密克戎是否是最后一个令人关注的 SARS-CoV-2 变体?
Arch Med Res. 2022 Apr;53(3):336-338. doi: 10.1016/j.arcmed.2022.01.001. Epub 2022 Jan 19.
8
Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022.2022 年 1 月至 2 月在中国浙江杭州发生的 SARS-CoV-2 奥密克戎变异株感染的传播动力学。
Int J Infect Dis. 2023 Jan;126:132-135. doi: 10.1016/j.ijid.2022.10.033. Epub 2022 Oct 28.
9
Transmission Characteristics and Predictive Model for Recent Epidemic Waves of COVID-19 Associated With OMICRON Variant in Major Cities in China.中国主要城市与奥密克戎变异株相关的 COVID-19 近期疫情波的传播特征及预测模型。
Int J Public Health. 2022 Nov 3;67:1605177. doi: 10.3389/ijph.2022.1605177. eCollection 2022.
10
Comparative analysis of prevention and control measures toward COVID-19 epidemic between Shanghai and Beijing.比较分析上海和北京针对 COVID-19 疫情的防控措施。
Front Public Health. 2023 Apr 17;11:1121846. doi: 10.3389/fpubh.2023.1121846. eCollection 2023.

引用本文的文献

1
Effects of non-pharmaceutical interventions on COVID-19 transmission: rapid review of evidence from Italy, the United States, the United Kingdom, and China.非药物干预措施对 COVID-19 传播的影响:来自意大利、美国、英国和中国的证据快速审查。
Front Public Health. 2024 Oct 17;12:1426992. doi: 10.3389/fpubh.2024.1426992. eCollection 2024.
2
Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.评估关注的 SARS-CoV-2 变异株的潜伏期、序列间隔和代时变化:系统评价和荟萃分析。
BMC Med. 2023 Sep 29;21(1):374. doi: 10.1186/s12916-023-03070-8.
3

本文引用的文献

1
Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.2022 年 1 月至 3 月,香港 SARS-CoV-2 奥密克戎 BA.2 变异株感染的流行病学。
Emerg Infect Dis. 2022 Sep;28(9):1856-1858. doi: 10.3201/eid2809.220613. Epub 2022 Aug 1.
2
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.BNT162b2 和科兴疫苗一剂、两剂和三剂对香港 COVID-19 的疫苗有效性:基于人群的观察性研究。
Lancet Infect Dis. 2022 Oct;22(10):1435-1443. doi: 10.1016/S1473-3099(22)00345-0. Epub 2022 Jul 15.
3
Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.
Effect of the Online Mindfulness-Based Stress Reduction on Anxiety and Depression Status of COVID-19 Patients Treated in Fangcang Hospitals: A Randomized Controlled Trial.
基于正念减压的在线干预对方舱医院收治的COVID-19患者焦虑和抑郁状态的影响:一项随机对照试验
Psychol Res Behav Manag. 2023 Jul 18;16:2735-2745. doi: 10.2147/PRBM.S414553. eCollection 2023.
马萨诸塞州在 COVID-19 的德尔塔和奥密克戎波期间的超额死亡率。
JAMA. 2022 Jul 5;328(1):74-76. doi: 10.1001/jama.2022.8045.
4
Crucial control measures to contain China's first Delta variant outbreak.遏制中国首例德尔塔变异株疫情的关键防控措施。
Natl Sci Rev. 2022 Jan 18;9(4):nwac004. doi: 10.1093/nsr/nwac004. eCollection 2022 Apr.
5
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity.抗原进化将导致具有不可预测严重程度的新型 SARS-CoV-2 变体。
Nat Rev Microbiol. 2022 May;20(5):251-252. doi: 10.1038/s41579-022-00722-z.
6
The Dynamic COVID-Zero Strategy in China.中国的动态清零战略
China CDC Wkly. 2022 Jan 28;4(4):74-75. doi: 10.46234/ccdcw2022.015.
7
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
8
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.严重急性呼吸综合征冠状病毒2型奥密克戎变异株B.1.1.529可导致广泛的中和抗体反应逃逸。
Cell. 2022 Feb 3;185(3):467-484.e15. doi: 10.1016/j.cell.2021.12.046. Epub 2022 Jan 4.
9
Omicron severity: milder but not mild.奥密克戎毒株的严重程度:症状较轻但并非轻微。
Lancet. 2022 Jan 29;399(10323):412-413. doi: 10.1016/S0140-6736(22)00056-3. Epub 2022 Jan 19.
10
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.一种传染性 SARS-CoV-2 B.1.1.529 奥密克戎病毒能够逃避治疗性单克隆抗体的中和作用。
Nat Med. 2022 Mar;28(3):490-495. doi: 10.1038/s41591-021-01678-y. Epub 2022 Jan 19.